ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 815

Incidence in Large Vessel GCA in Northern Italy during a 11-Year Period

Luigi Boiardi1, Giovanna Restuccia2, Pierluigi Macchioni3, Pamela Mancuso4, Mariagrazia Catanoso5, Francesco Muratore6, Filippo Crescentini1, Giulia Pazzola1, Nicolò Pipitone1 and Carlo Salvarani7, 1Rheumatology Unit, Arcispedale Santa Maria Nuova - IRCCS, Reggio Emilia, Italy, 2Rheumatology Unitn, Arcispedale S Maria Nuova, IRCCS, 42100, Italy, 3Rheumatology, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy, 4Interinstitutional Epidemiology Unit, Azienda USL di Reggio Emilia (Local Health Authority) and Azienda Ospedaliera IRCCS di Reggio Emilia,, Reggio Emilia, Italy, 5Rheumatology Service, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 6Rheumatology Unit, Arcispedale Santa Maria Nuova - IRCCS; Università di Modena e Reggio Emilia, Reggio Emilia, Italy, 7Rheumatology Unit, Arcispedale Santa Maria Nuova - IRCCS; Università di Modena e Reggio Emilia, Reggio-Emilia, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Epidemiologic methods, large vessel vasculitis and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Vasculitis Poster I: Large Vessel Vasculitis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: there are few studies regarding the incidence of large vessel GCA (LV GCA). Purpose: to investigate the incidence in patients diagnosed with large vessel GCA in the Reggio Emilia Area from 2005 through to 2016.

Methods: All patients with incident large vessel GCA diagnosed between 1 January 2005 and 31 December 2016 and living in the Reggio Emilia area, were identified by capture and re-capture checking of computerized discharge diagnosis codes (ICD10) and using outpatients databases from rheumatology, internal medicine, surgery, pathology, imaging departments of Reggio Emilia Hospital as well as by examining the Reggio Emilia district database for rare diseases. To be included in the study, patients must satisfy the following 2 criteria: Age at disease onset ≥ 50 years; evidence of large-vessel vasculitis by angiography, MRA, CTA, PET/CT and/or ultrasonography; we included in the study also patients associating biopsy proven gca to evidence of LVV at the imaging.

Results: There were 81 incident cases of LV GCA (57 women) during the 11-year study period; Mean ± SD age at diagnosis was 70 ± 9 years. Incidence per 100,000 persons aged ≥50 years was 3.38 (95% confidence interval [95% CI 2.69, 4.20]). Incidence was significantly higher in women (4.39 [95% CI 3.25, 5.53) than in men (2.19 [95% CI 1.31, 3.07]) (p <0.0036). Incidence rates significantly increased by 11.1% every 3 years from 2.86 (2005-2007) to 4.06 (2014-2016). The highest incidence in women and in man was observed in the 70–79 years age group (women 3.55 [95% CI 2.17,5.48; men 2,48 95% CI 1.24.,4.43).

Conclusion: The incidence of LV GCA in the Reggio Emilia area was 3.38 and it was lower than that of patients with biopsy proven GCA (5.8) (1); the incidence of LV GCA was signicantly higher in women as in biopsy proven GCA and increase during the follow-up period.

References

(1) Catanoso M, Macchioni P, Boiardi L, Muratore F, Restuccia G, Cavazza A, Pipitone N, Mancuso P, Luberto F, Salvarani C. Incidence, Prevalence, and Survival of Biopsy-Proven Giant Cell Arteritis in Northern Italy During a 26-Year Period. Arthritis Care Res (Hoboken). 2017 Mar;69(3):430-438


Disclosure: L. Boiardi, None; G. Restuccia, None; P. Macchioni, None; P. Mancuso, None; M. Catanoso, None; F. Muratore, None; F. Crescentini, None; G. Pazzola, None; N. Pipitone, None; C. Salvarani, None.

To cite this abstract in AMA style:

Boiardi L, Restuccia G, Macchioni P, Mancuso P, Catanoso M, Muratore F, Crescentini F, Pazzola G, Pipitone N, Salvarani C. Incidence in Large Vessel GCA in Northern Italy during a 11-Year Period [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/incidence-in-large-vessel-gca-in-northern-italy-during-a-11-year-period/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-in-large-vessel-gca-in-northern-italy-during-a-11-year-period/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology